Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: A prospective studyBone, 2011
- Pediatric Bone DensitometryRadiologic Clinics of North America, 2010
- Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)The Lancet Oncology, 2009
- Osteoporosis in children with cancerPediatric Blood & Cancer, 2007
- Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adultsArchives of Disease in Childhood, 2002
- Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemiaThe Journal of Pediatrics, 2002
- Continuing Positive Secular Growth Change in the Netherlands 1955–1997Pediatric Research, 2000
- Body index measurements in 1996-7 compared with 1980Archives of Disease in Childhood, 2000
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remissionCancer, 1970